The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
China's Sinovac vaccine creates "pandemic oasis" in Brazilian town: media
In Serrana, about a four-hour drive from the city of Sao Paulo, a vaccination campaign known as "Project S" has successfully inoculated 97.7 percent of its adult residents with the Chinese-made shot, Nikkei Asia reported.
China's Sinovac vaccine stands out in protecting health workers in Indonesia: health ministry
China's Sinovac vaccine against COVID-19 has appeared to be highly efficacious, as an overwhelming majority of vaccinated health workers were found protected from death and hospitalization, according to a Bloomberg report on Wednesday.
Additional batch of China's Sinovac vaccine arrives in Philippines
The Philippines received an additional batch of the Sinovac CoronaVac vaccine from China on Friday morning, said the country's Department of Health (DOH).
Philippines receives more Sinovac vaccines purchased from China
The Philippines on Sunday received the second batch of Sinovac Biotech's CoronaVac vaccines purchased from China.
Philippines allows elderly to receive China's Sinovac vaccine
Filipinos aged 60 and above can now receive China's Sinovac vaccine after the Philippines' Food and Drug Administration (FDA) allowed its use for senior citizens on Wednesday.
World Insights: Turkey's confidence in China-developed COVID-19 vaccine strengthens
Turkey announced on Wednesday that the China-developed Sinovac vaccine has an efficacy of 83.5 percent against COVID-19, furthering the country's confidence in winning the fight against the pandemic.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to email@example.com and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.